{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T06:57:09Z","timestamp":1784617029441,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.ejim.2016.05.019","type":"journal-article","created":{"date-parts":[[2016,6,11]],"date-time":"2016-06-11T19:52:27Z","timestamp":1465674747000},"page":"47-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Clinical management and outcome of major bleeding in patients on treatment with vitamin K antagonists"],"prefix":"10.1016","volume":"33","author":[{"given":"C.","family":"Becattini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Masotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Nitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Cattinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Cappelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Manina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Sbrojavacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Pomero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Agnelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2 Suppl.","key":"10.1016\/j.ejim.2016.05.019_bb0005","doi-asserted-by":"crossref","first-page":"e531S","DOI":"10.1378\/chest.11-2304","article-title":"Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"You","year":"2012","journal-title":"Chest"},{"issue":"2 Suppl.","key":"10.1016\/j.ejim.2016.05.019_bb0010","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"issue":"22","key":"10.1016\/j.ejim.2016.05.019_bb0015","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1016\/j.jacc.2014.02.537","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Nishimura","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2016.05.019_bb0020","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/europace\/euq350","article-title":"Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC)","volume":"12","author":"Camm","year":"2010","journal-title":"Europace"},{"issue":"43","key":"10.1016\/j.ejim.2016.05.019_bb0025","article-title":"2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism","volume":"35","author":"Konstantinides","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2016.05.019_bb0030","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2165\/00002512-199914040-00005","article-title":"Safety of treatment with oral anticoagulants in the elderly. A systematic review","volume":"14","author":"Hutten","year":"1999","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ejim.2016.05.019_bb0035","doi-asserted-by":"crossref","first-page":"257S","DOI":"10.1378\/chest.08-0674","article-title":"Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition)","volume":"133","author":"Schulman","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2016.05.019_bb0040","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1160\/TH08-11-0730","article-title":"Bleeding with anticoagulation therapy\u2014who is at risk, and how best to identify such patients","volume":"102","author":"Palareti","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2016.05.019_bb0045","doi-asserted-by":"crossref","first-page":"578","DOI":"10.7326\/0003-4819-152-9-201005040-00008","article-title":"Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism","volume":"152","author":"Carrier","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2016.05.019_bb0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0049-3848(02)00398-5","article-title":"Oral-anticoagulation related intracerebral hemorrhage","volume":"108","author":"Punthkee","year":"2002","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.ejim.2016.05.019_bb0055","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2016.05.019_bb0060","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/01.CIR.76.1.142","article-title":"Thrombolysis in myocardial infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge","volume":"76","author":"Chesebro","year":"1987","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ejim.2016.05.019_bb0065","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.amjmed.2006.07.034","article-title":"Death and disability from warfarin-associated intracranial and extracranial hemorrhages","volume":"120","author":"Fang","year":"2007","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.ejim.2016.05.019_bb0070","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1538-7836.2012.04636.x","article-title":"Failure to correct international normalized ratio and mortality among patients with warfarin-related major bleeding: an analysis of electronic health records","volume":"10","author":"Menzin","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.ejim.2016.05.019_bb0075","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/jth.12148","article-title":"Hospitalization for vitamin-K-antagonist-related bleeding: treatment patterns and outcome","volume":"11","author":"Halbritter","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.ejim.2016.05.019_bb0080","doi-asserted-by":"crossref","first-page":"R81","DOI":"10.1186\/cc13843","article-title":"Guideline-concordant administration of prothrombin complex concentrate and vitamin K is associated with decreased mortality in patients with severe bleeding under vitamin K antagonist treatment (EPAHK study)","volume":"18","author":"Tazarourte","year":"2014","journal-title":"Crit Care"},{"issue":"8","key":"10.1016\/j.ejim.2016.05.019_bb0085","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/archinte.164.8.880","article-title":"The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage","volume":"164","author":"Rosand","year":"2004","journal-title":"Arch Intern Med"},{"issue":"9","key":"10.1016\/j.ejim.2016.05.019_bb0090","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1161\/STR.0b013e3181ec611b","article-title":"Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"41","author":"Morgenstern","year":"2010","journal-title":"Stroke"},{"issue":"11","key":"10.1016\/j.ejim.2016.05.019_bb0095","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1161\/01.STR.31.11.2558","article-title":"Prediction of functional outcome and in-hospital mortality after admission with oral anticoagulant-related intracerebral hemorrhage","volume":"31","author":"Berwaerts","year":"2000","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.ejim.2016.05.019_bb0100","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1001\/archneur.65.10.1320","article-title":"Predictors of outcome in warfarin-related intracerebral hemorrhage","volume":"65","author":"Zubkov","year":"2008","journal-title":"Arch Neurol"},{"issue":"9","key":"10.1016\/j.ejim.2016.05.019_bb0105","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/ajh.21469","article-title":"Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: treatment","volume":"84","author":"Ageno","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ejim.2016.05.019_bb0110","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1399-6576.2011.02414.x","article-title":"Urgent reversal of vitamin K antagonist therapy","volume":"55","author":"Vang","year":"2011","journal-title":"Acta Anesthesiol Scand"},{"issue":"1","key":"10.1016\/j.ejim.2016.05.019_bb0115","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ana.24416","article-title":"Reversal strategies for vitamin K antagonists in acute intracerebral hemorrhage","volume":"78","author":"Parry-Jones","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ejim.2016.05.019_bb0120","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1161\/STROKEAHA.112.652065","article-title":"Poor prognosis in warfarin-associated intracranial hemorrhage despite anticoagulation reversal","volume":"43","author":"Dowlatshahi","year":"2012","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.ejim.2016.05.019_bb0125","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1160\/TH13-04-0318","article-title":"Questionable reversal of anticoagulation in the therapeutic management of cerebral haemorrhage associated with vitamin K antagonists","volume":"110","author":"Alonso de Leci\u00f1ana","year":"2013","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.ejim.2016.05.019_bb0130","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/imj.12034","article-title":"Warfarin-related intracerebral haemorrhage: better outcomes when reversal includes prothrombin complex concentrates","volume":"43","author":"Hanger","year":"2013","journal-title":"Intern Med J"},{"issue":"23","key":"10.1016\/j.ejim.2016.05.019_bb0135","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ejim.2016.05.019_bb0140","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2016.05.019_bb0145","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/europace\/euq350","article-title":"Guidelines for the management of atrial fibrillation: the task force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"12","author":"Camm","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.ejim.2016.05.019_bb0150","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2016.05.019_bb0155","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.ejim.2016.05.019_bb0160","doi-asserted-by":"crossref","first-page":"893","DOI":"10.7326\/0003-4819-139-11-200312020-00007","article-title":"Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis","volume":"139","author":"Linkins","year":"2003","journal-title":"Ann Intern Med"},{"issue":"9025","key":"10.1016\/j.ejim.2016.05.019_bb0165","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0140-6736(96)01109-9","article-title":"Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian study on complications of oral anticoagulant therapy","volume":"348","author":"Palareti","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2016.05.019_bb0170","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2016.05.019_bb0175","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.111.060871","article-title":"Validation of the Bleeding Academic Research Consortium definition of bleeding in patients with coronary artery disease undergoing percutaneous coronary intervention","volume":"125","author":"Ndrepepa","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2016.05.019_bb0180","series-title":"Clinical presentation, impact and course of major bleeding events with apixaban and warfarin. Poster presentation International Society Thrombosis Haemostasis","first-page":"PO353","author":"Bleker","year":"2015"},{"issue":"7","key":"10.1016\/j.ejim.2016.05.019_bb0185","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/ijs.12309","article-title":"European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage","volume":"9","author":"Steiner","year":"2014","journal-title":"Int J Stroke"},{"key":"10.1016\/j.ejim.2016.05.019_bb0190","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/jth.12111","article-title":"Prospective, multicenter validation of prediction scores for major bleeding in elderly patients with venous thromboembolism","volume":"11","author":"Scherz","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2016.05.019_bb0195","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1160\/TH14-01-0081","article-title":"Poor predictive value of contemporary bleeding risk scores during long-term treatment of venous thromboembolism. A multicentre retrospective cohort study","volume":"112","author":"Riva","year":"2014","journal-title":"Thromb Haemost"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620516301352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620516301352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T16:45:50Z","timestamp":1568047550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620516301352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":39,"alternative-id":["S0953620516301352"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2016.05.019","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical management and outcome of major bleeding in patients on treatment with vitamin K antagonists","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2016.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}